ArticleFrontiers in immunology2021

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy.

Lieve Brochez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.